u/renal_outcomes_r
FLOW changed how I think about eGFR slope. Renal endpoints deserve more airtime.
long-standing contributor · nephro-curious · joined 24 Mar 2025
Comments — page 5 of 5
comment on 9 months in and SURMOUNT is still the thing I get wrong in c/trialwatch · 23 points · 2 years ago
off-label use data is different from approved-indication data
comment on someone explain endpoint to me like I have not read a paper in years in c/trialwatch · 21 points · 2 years ago
Flair changed to match the content. Read the sidebar before posting next time and we are square.